Lv513
898 积分 2021-04-05 加入
Targeted Treatment for Hyperuricemia: The Drug Pipeline
4小时前
已完结
Discovery of a Novel Thienopyrimidine Derivative as a Potent Dual URAT1/GLUT9 Inhibitor with Enhanced Urate-Lowering Efficacy, Superior Pharmacokinetics, and Favorable Safety Profile for Gout and Hyperuricemia
4小时前
已完结
Remimazolam tosilate combined with remifentanil hydrochloride alleviates dental phobia in patients undergoing tooth extraction surgeries
4小时前
已完结
A Drug–Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia
1个月前
已完结
Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor
1个月前
已完结
Evaluating the drug-drug interactions of SHR4640 on repaglinide and midazolam in healthy subjects
1个月前
已完结
ANGPTL3-lowering strategies to address residual cardiovascular risk
1个月前
已关闭
ANGPTL3 inhibition for hypercholesterolaemia
1个月前
已完结
Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia
1个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of HRS ‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
1个月前
已完结
皖公网安备34019202002308
